INDEMNIFICATION AGREEMENTIndemnification Agreement • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations
Contract Type FiledOctober 16th, 2015 Company IndustryThis Indemnification Agreement (this “Agreement”) is made as of , 201 , by and among Hutchison China MediTech Limited, a company organized under the laws of the Cayman Islands (the “Company”), and each indemnitee executing and delivering this agreement (the “Indemnitee”).
English Translation SHANGHAI NO. 1 CHINESE MEDICINE CO. LTD. EQUITY JOINT VENTURE CONTRACT January 6, 2001Equity Joint Venture Contract • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations
Contract Type FiledOctober 16th, 2015 Company Industry[**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.
AMENDED AND RESTATED EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT between HUTCHISON MEDIPHARMA LIMITED and ELI LILLY TRADING (SHANGHAI) COMPANY LIMITED and HUTCHISON CHINA MEDITECH LIMITEDExclusive License and Collaboration Agreement • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations
Contract Type FiledOctober 16th, 2015 Company IndustryThis Agreement (the “Agreement”), effective as of 8th October 2013 (the “Effective Date”), is entered into by and among (i) Hutchison MediPharma Limited, a Chinese company, organized and existing under the laws of the People’s Republic of China, having a place of business at Building 4, 720 Cai Lun Road, ZJ Hi-Tech Park, Shanghai, PRC (“Hutchison”) and (ii) Eli Lilly and Company, an U.S.A. company, organized and existing under the laws of the State of Indiana, having a place of business at Lilly Corporate Center, Indianapolis, Indiana 46285 U.S.A. (“Lilly”), and (iii) solely for the purposes of Articles 7.11(a), 7.11(b) and 7.11(c), Hutchison China MediTech Limited, a company organized and existing under the laws of the Cayman Islands with its principal offices at PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (the “Hutchison Guarantor”). Hutchison and Lilly may be referred to herein individually as a “Party” or collectively as the “Parties.” Reference to a Party shal
OPTION AGREEMENT between HUTCHISON CHINA MEDITECH LIMITED and ELI LILLY AND COMPANYOption Agreement • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations
Contract Type FiledOctober 16th, 2015 Company IndustryThis Agreement (the “Agreement”), effective as of 8th October 2013 (the “Effective Date”), is entered into by and among Hutchison China MediTech Limited, a company organized and existing under the laws of the Cayman Islands with its principal offices at PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (“Hutchison”) and Eli Lilly and Company, an U.S.A. company, organized and existing under the laws of the State of Indiana, having a place of business at Lilly Corporate Center, Indianapolis, Indiana 46285 U.S.A(“Lilly”). Hutchison and Lilly may be referred to herein individually as a “Party” or collectively as the “Parties.” Reference to a Party shall be deemed to include that Party’s Affiliates.
DATED 15 April 2011Shares Provision Agreement • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations • England and Wales
Contract Type FiledOctober 16th, 2015 Company Industry Jurisdiction
English Translation Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Equity Joint Venture Contract November 28, 2004Equity Joint Venture Contract • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations
Contract Type FiledOctober 16th, 2015 Company Industry[**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.
English Translation THIRD AMENDMENT TO JOINT VENTURE CONTRACTJoint Venture Contract • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations
Contract Type FiledOctober 16th, 2015 Company IndustryTHIS THIRD AMENDMENT TO JOINT VENTURE CONTRACT (the “Amendment No.3”) is entered into by and between the following Parties in Shanghai Municipality, China as of June 19, 2012:
English Translation AMENDMENT TO JOINT VENTURE CONTRACTJoint Venture Contract • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations
Contract Type FiledOctober 16th, 2015 Company IndustryTHIS AMENDMENT TO JOINT VENTURE CONTRACT (the “Amendment”) is entered into as of July 12, 2001 in Shanghai, China by and between the following parties:
LICENSE AND COLLABORATION AGREEMENT by and betweenLicense and Collaboration Agreement • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations • England
Contract Type FiledOctober 16th, 2015 Company Industry JurisdictionThis LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into on this 21st day of December, 2011 (the “Effective Date”), by and among 和记黄埔医药(上海)有限公司 Hutchison Medipharma Limited, a company organized under the laws of the People’s Republic of China, having its place of business at Building 4, 720 Cailun Road, Zhangjiang Hi-Tech Park, Shanghai 201203, P.R. China (“Hutchison”) and AstraZeneca AB(publ) , a company organized under the laws of Sweden, having its place of business at S-151 85 Södertälje, Sweden (“AstraZeneca”). Hutchison and AstraZeneca may each be referred to herein individually as a “Party” and collectively as the “Parties.”
English Translation FOURTH AMENDMENT TO JOINT VENTURE CONTRACTJoint Venture Contract • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations
Contract Type FiledOctober 16th, 2015 Company IndustryTHIS FOURTH AMENDMENT TO JOINT VENTURE CONTRACT (the “Amendment No.4”) is entered into by and between the following Parties in Shanghai Municipality, China on March 8, 2013:
English Translation Hutchison Whampoa Sinopharm Pharmaceuticals (Shanghai) Company Limited Equity Joint Venture ContractEquity Joint Venture Contract • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations
Contract Type FiledOctober 16th, 2015 Company Industry[**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.
The Second Amendment to the Joint Venture Contract relating to the formation of Shanghai Hutchison Pharmaceuticals LimitedJoint Venture Contract • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations
Contract Type FiledOctober 16th, 2015 Company IndustryTHIS SECOND AMENDMENT TO JOINT VENTURE CONTRACT (the “Amendment No.2”) is entered into by and between the following Parties in Shanghai Municipality, China on this 5th day of November 2007:
DATED 6 August 2008Shares Agreement • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations • England and Wales
Contract Type FiledOctober 16th, 2015 Company Industry Jurisdiction
GUARANTEE FEE AGREEMENTGuarantee Fee Agreement • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations • Hong Kong
Contract Type FiledOctober 16th, 2015 Company Industry JurisdictionHUTCHISON CHINA MEDITECH FINANCE HOLDINGS LIMITED of P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands (“Company”) of the other part.
DATED 17 December 2014Shares Provision Agreement • October 16th, 2015 • Hutchison China MediTech LTD • Pharmaceutical preparations • England and Wales
Contract Type FiledOctober 16th, 2015 Company Industry Jurisdiction